Deutsches Zentrum fur Neurodegenerative Erkrankungen

• European Research Council

  HORIZON-ERC-POC, Gene therapeutic conversion from APOE4 to APOE3 to prevent Alzheimer’s disease, 101292850, €150k, 2026–2027, 26 Mar 2026

• European Research Council

  ERC-COG, Re-Defining early Parkinson’s disease, 101169580, €933.8k, 2025–2030, 25 Jul 2025

• European Commission

  HORIZON-TMA-MSCA-DN, BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence, 101225642, €290.3k, 2025–2029, 30 Jun 2025

• European Commission

  HORIZON-RIA, Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification, 101156175, €853.7k, 2024–2029, 9 Nov 2024

Sources: cordis.europa.eu

• Technology-natives and technology-adopters: Age differences in remote cognitive assessment in Alzheimer disease

  1 Sept 2026

• BOLD fMRI activations and LC contrast associated with successful episodic memory in healthy older adults and MCI

  (DZNE) D‐39120, 1 Aug 2026

• Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging

  6 Feb 2026

Sources: api.crossref.org